The store will not work correctly when cookies are disabled.
2-((3-bromophenyl)amino)-2-oxoethyl(E)-2-(pyridin-2-ylmethylene)hydrazine-1-carbodithioate
ID: ALA4174582
PubChem CID: 145951265
Max Phase: Preclinical
Molecular Formula: C15H13BrN4OS2
Molecular Weight: 409.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CSC(=S)N/N=C/c1ccccn1)Nc1cccc(Br)c1
Standard InChI: InChI=1S/C15H13BrN4OS2/c16-11-4-3-6-12(8-11)19-14(21)10-23-15(22)20-18-9-13-5-1-2-7-17-13/h1-9H,10H2,(H,19,21)(H,20,22)/b18-9+
Standard InChI Key: MPHBUSZUVYKVEA-GIJQJNRQSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
11.1906 -12.5117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4829 -12.1031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8983 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6060 -12.5117 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.8983 -11.2859 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.7752 -12.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0675 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3598 -12.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6521 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6521 -11.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3598 -10.8773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0675 -11.2859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3138 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3138 -11.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6060 -10.8773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0215 -10.8773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7292 -11.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4369 -10.8773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1446 -11.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1446 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4369 -12.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7292 -12.1031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8523 -10.8773 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 4 1 0
3 5 2 0
1 3 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
6 7 1 0
2 6 2 0
13 14 1 0
14 15 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
19 23 1 0
16 17 1 0
14 16 1 0
4 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 409.33 | Molecular Weight (Monoisotopic): 407.9714 | AlogP: 3.42 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.38 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.84 | CX Basic pKa: 3.05 | CX LogP: 4.20 | CX LogD: 4.20 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -2.28 |
References
1. Bhattacharjee A, Sinha A, Ratia K, Yin L, Delgado-Rivera L, Petukhov PA, Thatcher GRJ, Wardrop DJ.. (2017) 2-Arylidene Hydrazinecarbodithioates as Potent, Selective Inhibitors of Cystathionine γ-Lyase (CSE)., 8 (12): [PMID:29259741] [10.1021/acsmedchemlett.7b00313] |